TC
CRSP icon

Trilogy Capital’s CRISPR Therapeutics CRSP Stock Holding History

Trilogy Capital’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,900
Closed -$230K – 331
2024
Q3 		$230K Hold
4,900
– – 0.01% 301
2024
Q2 		$265K Buy
+4,900
New +$265K 0.01% 285